HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Henney hearing follow-up

This article was originally published in The Rose Sheet

Executive Summary

Senate Labor & Human Resources committee member Dan Coats (R- Ind.) asks Commissioner-nominee Jane Henney, MD, to "reconcile" her position on supporting industry/agency collaboration with the recent FDA announcement that the agency will not share information or solicit comments regarding implementation of the FDA Modernization Act. In a separate series of follow-up questions, Committee Chairman James Jeffords (R-Vt.) asks Henney to explain what she meant by "enhancing FDA's science base" during her testimony. Henney appeared before the committee Sept. 2 ("The Rose Sheet" Sept. 7, p. 10)...



Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts